What is Haemonetics's price / book?

Haemonetics (HAE) reported price / book of 3.3× in Q1 2026.

How has Haemonetics's price / book changed year-over-year?

Haemonetics's price / book decreased by 15.4% year-over-year, from 3.9× to 3.3×.

What is the long-term trend for Haemonetics's price / book?

Over 5 years (2021 to 2026), Haemonetics's price / book has grown at a -15.8% compound annual growth rate (CAGR), from 7.8× to 3.3×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Haemonetics HAE Price / book

Price / book at other companies

AbbottABT

3.4×-1.3×

TFX

TeleflexTFX

1.7×+0.2×

Boston ScientificBSX

3.6×-3.1×

MedtronicMDT

2.1×-0.1×

LivaNovaLIVN

2.9×+0.8×

ICU MedicalICUI

1.5×-0.2×

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

market cap/total stockholders equity=3.3×

Based on the most recent quarter.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's price / book?: Haemonetics (HAE) reported price / book of 3.3× in Q1 2026.
How has Haemonetics's price / book changed year-over-year?: Haemonetics's price / book decreased by 15.4% year-over-year, from 3.9× to 3.3×.
What is the long-term trend for Haemonetics's price / book?: Over 5 years (2021 to 2026), Haemonetics's price / book has grown at a -15.8% compound annual growth rate (CAGR), from 7.8× to 3.3×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.